Since joining GLSV, Jung has been involved in a wide range of investment-related activities, including deal sourcing, analyzing investment opportunities, conducting due diligence and arranging investor syndicates. He is also representing GLSV as member of the supervisory board of Action Pharma A/S, Denmark, whose Series D he led in December 2007.